Sponsor pipeline

Fox Chase Cancer Center clinical trial pipeline

Get alerts when Fox Chase Cancer Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

6 trials changed in the last 30 days: 1 stopped, 4 with notable changes, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-02 NCT07854769 Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell… Not Yet Recruiting

Active trials by phase

Early Phase 1
3
Phase 1
5
Phase 1/2
1
Phase 2
19
Phase 3
1
Not charted: 18 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 22

Bladder Cancer (9) · Pancreatic Cancer (5) · Colorectal Cancer (4) · Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (4) · Breast Cancer (3) · Kidney Cancer (3) · Sarcoma (3) · Gastric Cancer (2) · Head & Neck Cancer (2)

Get alerts when Fox Chase Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free